BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//www.insightmcc.org//NONSGML kigkonsult.se iCalcreator 2.30.10//
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:60391483-8b6b-44e1-9e23-9a3fa66c5ade
X-WR-CALDESC:Today in the United States\, there are no medications approved
for the treatment of dementia with Lewy bodies (DLB) and only a single dr
ug approved for Parkinson's disease dementia (PDD\; the other major form o
f Lewy body dementia [LBD])\, and that is only approved to treat hallucina
tions and delusions. That is changing. In fact\, within the last 6 months
alone\, researchers have reported promising results from three different P
hase 2 clinical trials in people with LBD. In this presentation\, you will
learn the results of these trials\, hear about scientific breakthroughs t
hat are speeding progress in LBD trials\, and learn where to find out more
if you or someone you know may be interested in volunteering for ongoing
or future research studies.\n\nZoom link provided upon registration.\n\n \;Sign Me Up!\n\n\n \;\nPresenter\nKeith Fargo\, P
hD\nDirector of Scientific Initiatives\nLewy Body Dementia Association\n\n
Keith N. Fargo\, PhD\, is the Director of Scientific Initiatives at the Le
wy Body Dementia Association. Dr. Fargo earned his PhD in Neuroscience fro
m Indiana University\, where his research focused on the effects of hormon
es on the structure and function of spinal cord neurons that control movem
ent. In his current role at the Lewy Body Dementia Association\, he is res
ponsible for the research activities of the LBDA\, including the flagship
LBDA Research Centers of Excellence\, a network of 20 of the nation’s lead
ing academic medical institutions focused on advancing our understanding o
f the disease\, improving care\, and carrying out clinical trials for Lewy
body dementias.\n\n\n
X-WR-RELCALID:7e47efb9da82a7f13298a4b2b6c50247
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
TZNAME:EST
DTSTART:20241103T020000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RDATE:20251102T020000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:EDT
DTSTART:20250309T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RDATE:20260308T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:bd2b8a35-2998-4932-a0ad-140a630be842
DTSTAMP:20260422T033635Z
DESCRIPTION:Today in the United States\, there are no medications approved
for the treatment of dementia with Lewy bodies (DLB) and only a single dru
g approved for Parkinson's disease dementia (PDD\; the other major form of
Lewy body dementia [LBD])\, and that is only approved to treat hallucinat
ions and delusions. That is changing. In fact\, within the last 6 months a
lone\, researchers have reported promising results from three different Ph
ase 2 clinical trials in people with LBD. In this presentation\, you will
learn the results of these trials\, hear about scientific breakthroughs th
at are speeding progress in LBD trials\, and learn where to find out more
if you or someone you know may be interested in volunteering for ongoing o
r future research studies.\n\nZoom link provided upon registration.
\n\n \;Sign Me Up!\n\n\n \;\nPresenter\nKeith Fargo\, Ph
D\nDirector of Scientific Initiatives\nLewy Body Dementia Association\n\nK
eith N. Fargo\, PhD\, is the Director of Scientific Initiatives at the Lew
y Body Dementia Association. Dr. Fargo earned his PhD in Neuroscience from
Indiana University\, where his research focused on the effects of hormone
s on the structure and function of spinal cord neurons that control moveme
nt. In his current role at the Lewy Body Dementia Association\, he is resp
onsible for the research activities of the LBDA\, including the flagship L
BDA Research Centers of Excellence\, a network of 20 of the nation’s leadi
ng academic medical institutions focused on advancing our understanding of
the disease\, improving care\, and carrying out clinical trials for Lewy
body dementias.\n\n\n
DTSTART;TZID=America/New_York:20250415T190000
DTEND;TZID=America/New_York:20250415T200000
LOCATION:Virtual! Zoom link provided upon registration.
SUMMARY:Lewy Body Dementia and Current Research Studies
END:VEVENT
END:VCALENDAR